Scholars Central

Research articlePublished 17 Jan 2016

SGLT2 Inhibitor and DPP4 Inhibitor Co-Administration In Type 2 Diabetes -Are We Near The Promised Land?

Authors: Ayesha Vaseem, Bipin K Sethi, Jayant V Kelwade, Mazher Ali

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetes is progressive disease needing multiple drugs for achieving and maintaining good glycemic control. The drugs with different mechanisms of action are administered either alone or as fixed dose combinations. Usually the combined effect of each is less than the added effect except with Metformin DPP-4 inhibitor combination because they seldom complement/synergise each other’s action. More of such effective drug combinations that provide glycemic control are needed. SGLT 2 inhibitor, when combined with DPP4 inhibitor has the potential to be that ideal combination. Both of these drugs address different pathophysiological mechanisms for hyperglycemia and when combined provide reductions in HbA1c level with no inherent risk of hypoglycaemia. Genitourinary infection, a major hindrance with SGLT 2 inhibitor use are potentially reduced when it is combined with DPP4 inhibitor, which also can counteract the increase in glucagon level produced by the former. Cost, differing applicability in patients with renal dysfunction and limited clinical experience restricts the universal application of this combination as first line agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Research & Reviews: Journal of Pharmacology and Toxicological Studies.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch & Reviews: Journal of Pharmacology and Toxicological Studies
  • SubjectPharmaceutical Sciences
  • SubjectToxicology
  • BylineArticles whose byline prints “Ayesha Vaseem”
  • BylineArticles whose byline prints “Bipin K Sethi”
  • BylineArticles whose byline prints “Jayant V Kelwade”
  • BylineArticles whose byline prints “Mazher Ali”